- Home
- OST vs VYNE Comparison
OST vs VYNE Comparison
Compare OST & VYNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- VYNE
- Stock Information
- Founded
- OST 2010
- VYNE 2003
- Country
- OST China
- VYNE United States
- Employees
- OST N/A
- VYNE N/A
- Industry
- OST Industrial Machinery/Components
- VYNE Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- VYNE Health Care
- Exchange
- OST Nasdaq
- VYNE Nasdaq
- Market Cap
- OST 15.7M
- VYNE 16.0M
- IPO Year
- OST 2022
- VYNE 2018
- Fundamental
- Price
- OST $0.10
- VYNE $1.45
- Analyst Decision
- OST
- VYNE Strong Buy
- Analyst Count
- OST 0
- VYNE 2
- Target Price
- OST N/A
- VYNE $6.25
- AVG Volume (30 Days)
- OST 36.1M
- VYNE 853.5K
- Earning Date
- OST 08-25-2025
- VYNE 08-13-2025
- Dividend Yield
- OST N/A
- VYNE N/A
- EPS Growth
- OST N/A
- VYNE N/A
- EPS
- OST N/A
- VYNE N/A
- Revenue
- OST $38,333,251.00
- VYNE $605,000.00
- Revenue This Year
- OST N/A
- VYNE $42.51
- Revenue Next Year
- OST N/A
- VYNE N/A
- P/E Ratio
- OST N/A
- VYNE N/A
- Revenue Growth
- OST 0.34
- VYNE 43.03
- 52 Week Low
- OST $0.10
- VYNE $0.85
- 52 Week High
- OST $9.40
- VYNE $4.30
- Technical
- Relative Strength Index (RSI)
- OST 25.01
- VYNE 56.14
- Support Level
- OST $0.10
- VYNE $1.30
- Resistance Level
- OST $0.13
- VYNE $1.49
- Average True Range (ATR)
- OST 0.01
- VYNE 0.15
- MACD
- OST 0.17
- VYNE 0.01
- Stochastic Oscillator
- OST 7.00
- VYNE 70.71
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About VYNE VYNE Therapeutics Inc.
VYNE Therapeutics Inc is a biopharmaceutical company focused on developing proprietary, innovative and differentiated therapies for the treatment of immuno-inflammatory conditions. Its advanced product candidate is FMX114, which is being evaluated for the potential treatment of mild-to-moderate AD (atopic dermatitis). The company is also in the pre-clinical stages of developing products containing BET (Bromodomain and Extra-Terminal Domain) inhibitor compounds. Its products include AMZEEQ, ZILXI, and FCD105.